Mesothelioma Prognosis Improves when Surgery is Paired with Chemotherapy Treatment
Researchers in London have estimated that when a malignant mesothelioma patient undergoes surgery to remove a portion of the cancerous lining of the lung or abdomen the survival rate increases by approximately nine months.
The researchers further found that mesothelioma patients who had multi-modal treatment of surgery and chemotherapy or radiotherapy showed the best results. They survived about 32 months on average – or roughly twice as long as patients who had other types of treatments.
Mesothelioma is a cancer of the lining of the lung or abdomen closely associated with asbestos exposure. Although there is no cure for mesothelioma, it can be treated with varying degrees of success through the use of surgical procedures, chemotherapy and radiation.
When analyzing the results of the types of treatment, the researchers divided the treatment data into four groups:
- Mesothelioma patients who did not have surgery;
- Mesothelioma patients who had their chest cavity opened surgically, but did not have organs removed;
- Mesothelioma patients who had tissue such as a lung and the lining of the lung removed, but did not undergo chemotherapy afterward;
- Mesothelioma patients who had organs and cancerous tumors removed as well as receiving chemotherapy and/or radiation.
Researchers at the University College London published the results in the European Journal of Cardiothoracic Surgery.